Variant report

Variant	esv9650
Chromosome Location	chr1:241586127-241586636
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	JUN	chr1:241586419-241586421	K562	blood:	n/a	n/a
2	TCF12	chr1:241586614-241587207	SK-N-SH	brain:	n/a	n/a

Variant related genes	Relation type
ENSG00000225554	TF binding region

Extended variants
information (count: 29 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:29 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs527728451	chr1:241586143-241586144	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs569776560	chr1:241586157-241586158	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs112886680	chr1:241586163-241586164	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs116440961	chr1:241586185-241586186	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs572666126	chr1:241586224-241586225	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs5782195	chr1:241586230-241586231	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs77541746	chr1:241586247-241586248	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs1539102	chr1:241586280-241586281	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs576954568	chr1:241586292-241586293	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs545775029	chr1:241586332-241586333	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs562573061	chr1:241586336-241586337	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs576058045	chr1:241586338-241586339	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs112725506	chr1:241586345-241586346	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs1539103	chr1:241586376-241586377	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs184412505	chr1:241586386-241586387	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs146105390	chr1:241586397-241586398	Weak transcription Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs188104556	chr1:241586425-241586426	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs192713199	chr1:241586446-241586447	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs112225840	chr1:241586458-241586459	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs185273564	chr1:241586461-241586462	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs145931687	chr1:241586463-241586464	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs201308917	chr1:241586488-241586489	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs569838588	chr1:241586515-241586516	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs529355908	chr1:241586520-241586521	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs112098876	chr1:241586542-241586543	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs55825634	chr1:241586557-241586558	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs566291684	chr1:241586589-241586590	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs114197882	chr1:241586591-241586592	Weak transcription Enhancers Bivalent Enhancer Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs558496984	chr1:241586632-241586633	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Liposarcoma	21253554	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	21899760	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Breast cancer	21509527	CNVD
Urothelial carcinoma	21177765	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Chordoma	18071362	CNVD
T-cell lymphomas	19863542	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hepatocellular carcinoma	18803288	CNVD
Urothelial tumor	18831757	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Basal cell lymphoma	17170743	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Mental retardation	21549014	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164920	CNVD
Cancer	17060936	CNVD
abnormal development	18461090	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Hepatocellular carcinoma	16750200	CNVD
Arrhythmogenic right ventricular cardiomyopathy	17576883	CNVD
Multiple myeloma	16616336	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
Schizophrenia	17989066	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:30 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:241574200-241587000	Weak transcription	Gastric	stomach
2	chr1:241577600-241586600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr1:241582200-241586600	Enhancers	NHDF-Ad	bronchial
4	chr1:241584000-241587000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr1:241585000-241586600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
6	chr1:241585400-241586800	Enhancers	NHLF	lung
7	chr1:241585600-241586400	Enhancers	Pancreatic Islets	Pancreatic Islet
8	chr1:241585800-241586600	Weak transcription	Osteobl	bone
9	chr1:241586000-241586200	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr1:241586000-241586200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr1:241586000-241586600	Enhancers	Muscle Satellite Cultured Cells	--
12	chr1:241586000-241586800	Active TSS	Brain Anterior Caudate	brain
13	chr1:241586000-241587000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr1:241586200-241586800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr1:241586400-241586600	Enhancers	Fetal Brain Male	brain
16	chr1:241586400-241586800	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
17	chr1:241586600-241586800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
18	chr1:241586600-241586800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
19	chr1:241586600-241586800	Enhancers	Brain Angular Gyrus	brain
20	chr1:241586600-241586800	Enhancers	Brain Substantia Nigra	brain
21	chr1:241586600-241586800	Flanking Active TSS	NHDF-Ad	bronchial
22	chr1:241586600-241586800	Flanking Active TSS	Osteobl	bone
23	chr1:241586600-241587000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
24	chr1:241586600-241587000	Flanking Active TSS	Muscle Satellite Cultured Cells	--
25	chr1:241586600-241587000	Active TSS	Fetal Brain Male	brain
26	chr1:241586600-241587400	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr1:241586600-241588200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr1:241586600-241588200	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr1:241586600-241588200	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr1:241586600-241588200	Active TSS	Brain Inferior Temporal Lobe	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links